These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28545084)

  • 1. Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    Mabrouk R; Strafella AP; Knezevic D; Ghadery C; Mizrahi R; Gharehgazlou A; Koshimori Y; Houle S; Rusjan P
    PLoS One; 2017; 12(5):e0177785. PubMed ID: 28545084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial activation in Parkinson's disease using [
    Ghadery C; Koshimori Y; Coakeley S; Harris M; Rusjan P; Kim J; Houle S; Strafella AP
    J Neuroinflammation; 2017 Jan; 14(1):8. PubMed ID: 28086916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
    Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based input function for TSPO quantification and kinetic modeling with [
    Akerele MI; Zein SA; Pandya S; Nikolopoulou A; Gauthier SA; Raj A; Henchcliffe C; Mozley PD; Karakatsanis NA; Gupta A; Babich J; Nehmeh SA
    EJNMMI Phys; 2021 Apr; 8(1):39. PubMed ID: 33914185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of [
    Meindl M; Zatcepin A; Gnörich J; Scheifele M; Zaganjori M; Groß M; Lindner S; Schaefer R; Simmet M; Roemer S; Katzdobler S; Levin J; Höglinger G; Bischof AC; Barthel H; Sabri O; Bartenstein P; Saller T; Franzmeier N; Ziegler S; Brendel M
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3252-3266. PubMed ID: 38717592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies.
    Zanotti-Fregonara P; Maroy R; Peyronneau MA; Trebossen R; Bottlaender M
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):651-9. PubMed ID: 22231015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
    Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.
    Suridjan I; Pollock BG; Verhoeff NP; Voineskos AN; Chow T; Rusjan PM; Lobaugh NJ; Houle S; Mulsant BH; Mizrahi R
    Mol Psychiatry; 2015 Dec; 20(12):1579-87. PubMed ID: 25707397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients.
    Zatcepin A; Kopczak A; Holzgreve A; Hein S; Schindler A; Duering M; Kaiser L; Lindner S; Schidlowski M; Bartenstein P; Albert N; Brendel M; Ziegler SI
    Z Med Phys; 2024 May; 34(2):218-230. PubMed ID: 36682921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic modelling and quantification bias in small animal PET studies with [18F]AB5186, a novel 18 kDa translocator protein radiotracer.
    MacAskill MG; Walton T; Williams L; Morgan TEF; Alcaide-Corral CJ; Dweck MR; Gray GA; Newby DE; Lucatelli C; Sutherland A; Pimlott SL; Tavares AAS
    PLoS One; 2019; 14(5):e0217515. PubMed ID: 31150436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
    Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L
    J Nucl Med; 2012 Mar; 53(3):415-24. PubMed ID: 22323782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
    Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
    Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Invasive and Non-invasive Estimation of [
    Aceves-Serrano L; Sossi V; Doudet DJ
    Mol Imaging Biol; 2022 Jun; 24(3):404-415. PubMed ID: 34622422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.